멀티모달 이미징 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Multimodal Imaging Market size is expected to reach USD 8.38 Billion in 2034 from USD 5.22 Billion (2025) growing at a CAGR of 5.41% during 2026-2034.

The Global Multimodal Imaging Market is witnessing steady growth due to increasing demand for comprehensive diagnostic solutions. Multimodal imaging combines different imaging techniques such as PET/CT and MRI/CT to provide detailed anatomical and functional information. Rising prevalence of chronic diseases is driving adoption in oncology and neurology.

Key growth drivers include advancements in imaging technologies and integration with AI-based analysis tools. Healthcare providers are investing in hybrid imaging systems to improve diagnostic accuracy. Expanding healthcare infrastructure and growing research in medical imaging are further supporting market expansion. Additionally, increasing focus on early disease detection is strengthening demand.

Looking ahead, the market is expected to benefit from technological innovations enhancing image resolution and workflow efficiency. Emerging markets upgrading diagnostic facilities will create new growth opportunities. Companies are focusing on compact and cost-effective hybrid systems. As precision diagnostics advance, the Global Multimodal Imaging Market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Equipment
• Reagent
• Software

By Technology

• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/Fundus Imaging Systems
• Other Multimodal Imaging Systems

By Application

• Oncology
• Ophthalmology
• Cardiology
• Brain & Neurology
• Other Applications

By End User

• Hospitals
• Diagnostic Imaging Centres
• Other

COMPANIES PROFILED

• GE Healthcare, Siemens Healthcare GmbH, Toshiba medical Systems Corporation, Hitachi Medical Systems, Samsung Medison CoLtd, Koninklijke Philips NV, Shimadzu Corporation, Carestream Health, Fujifilm Holdings, Esaote
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MULTIMODAL IMAGING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MULTIMODAL IMAGING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. PET/CT Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. SPECT/CT Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. PET/MR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. OCT/Fundus Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Multimodal Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MULTIMODAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Brain & Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MULTIMODAL IMAGING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Imaging Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MULTIMODAL IMAGING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MULTIMODAL IMAGING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 GE Healthcare
  • 10.2.2 Siemens Healthcare GmbH
  • 10.2.3 Toshiba Medical Systems Corporation
  • 10.2.4 Hitachi Medical Systems
  • 10.2.5 Samsung Medison Co.Ltd
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 Shimadzu Corporation
  • 10.2.8 Carestream Health
  • 10.2.9 Fujifilm Holdings
  • 10.2.10 Esaote